Brief: Neurizon Therapeutics Logs HY Loss Attributable A$7.3 Mln
17/02/2025 06:05
Feb 17 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX :
* HY LOSS ATTRIBUTABLE A$7.3 MILLION
* HY OTHER INCOME A$1.8 MILLION
Further company coverage: NUZ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO